Xycrobe Therapeutics, Inc.

Xycrobes™ are skin-derived "good" bacteria that are engineered to colonize the skin and release skin-healthy bio-therapeutics to the target tissues.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Diego, CA, US
  • Currency USD
  • Founded July 2014
  • Employees 9
  • Incorporation Type C-corp
  • Website xycrobe.com

Company Summary

Patent-pending Xycrobes™ are skin-derived "good" bacteria that are engineered to colonize the skin and release skin-healthy bio-therapeutics to the target tissues. Xycrobes are naturally anti-inflammatory, naturally produce anti-oxidants as potent as Vitamin C / E and naturally reduce the number of S. aureus on the skin.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free